Advertisement

Topics

PARI Respiratory Equipment, Inc. Company Profile

13:25 EST 16th December 2018 | BioPortfolio

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.


News Articles [629 Associated News Articles listed on BioPortfolio]

EU Panel Recommends Tobramycin PARI for Pseudomonas in CF

The European Medicines Agency's Committee for Medicinal Products for Human Use recommended Tobramycin PARI for Pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis. Intern...

Global Respiratory Protective Equipment Market- Technologies, Market share and Industry ...

LONDON, Oct. 18, 2018 /PRNewswire/ -- Respiratory protective equipment is a type of protective equipment's that are used to protect the individual wearers from the Read more...

US FDA approves PARI Pharma's eFlow technology nebulizer, Lamira with Insmed's Arikayce

PARI Pharma GmbH, a company focused on the development and commercialization of advanced aerosol delivery systems based on eFlow Technology, announces approval of its optimized eFlow technology

Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment

Reliable Respiratory, one of New England's leading home respiratory and specialty medical equipment providers, today announced the acquisition of Attleboro Area Medical Equipment of Attleboro, Mass.

Reliable Respiratory Acquires Attleboro Area Medical Equipment

Medical Equipment Provider Accelerates Growing Service and Supply Network Coverage in New England Region Reliable Respiratory, one of New England’s leading home re...

Summary of opinion: Tobramycin PARI,tobramycin, 13/12/2018, Positive

Summary of opinion: Tobramycin PARI,tobramycin, 13/12/2018, Positive

Pulmonologists call for speedy respiratory drug development and approval process

With the increasing burden of respiratory diseases globally and particularly in India, and the burgeoning costs of inhaled medications that are projected to run into billions of dollars, pulmonology a...

Middle East respiratory syndrome

Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. Cases have been limited to the Arabian Peninsula and its surrounding countr...

PubMed Articles [1362 Associated PubMed Articles listed on BioPortfolio]

Respiratory alterations in workers: study of single ports.

To identify alterations in the respiratory system in port workers through radiographic and pulmonary function tests; to identify the use of personal protective equipment during port activities; and to...

Does the Size of a Company Make a Difference in the Prevalence of Exposure to Asthmagens and in the Use of Respiratory Protective Equipment?

About half of all workers in high-income countries work in small companies. However, regulatory bodies and researchers predominantly work with large companies because they are more convenient to study...

CLEAR: A Novel Approach to Ultrasound Equipment Homeostasis.

Protocols for the sanitation and maintenance of point-of-care ultrasound (US) equipment are lacking. This study introduces the CLEAR protocol (clean, locate, energize, augment supplies, and remove pat...

Nickel release from surgical instruments and operating room equipment.

Background There has been no systematic study assessing nickel release from surgical instruments and equipment used within the operating suite. This equipment represents important potential sources of...

Respiratory Viruses and Atypical Bacteria Co-Infection in Children with Acute Respiratory Infection.

Acute respiratory infections (ARI) are one of the prevalent pediatric diseases. Coinfections of respiratory viruses and atypical bacterial respiratory pathogens are common.

Clinical Trials [2570 Associated Clinical Trials listed on BioPortfolio]

Construction of the Training Mode Adjustable Equipment Sitting Volleyball

The individual adapted sport modalities concentrate most of the technological development for equipment and auxiliary devices, the collective modalities need implements that aid in the dev...

Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

This study assesses the aerosol delivery characteristics (measured by nebulization time, serum and sputum tobramycin pharmacokinetic parameters) and safety of tobramycin administered for i...

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

The study should create data for the selection of a clinically relevant primary endpoint to assess the efficacy and safety of Buparid/PARI SINUS as compared to Budes Nasal Spray in the the...

Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study

This study assesses the aerosol delivery characteristics (measured by in vivo lung deposition, nebulization time, serum tobramycin concentrations, and pharmacokinetic parameters) and safet...

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

This study will evaluate systemic and urine pharmacokinetics in spontaneously breathing healthy volunteers following a single dose of amikacin/fosfomycin, using the PARI Investigational eF...

Companies [1189 Associated Companies listed on BioPortfolio]

PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is t...

PARI Pharma

PARI Pharma focuses on the development of aerosol delivery devices and comprehensive inhalation drug development to advance aerosol therapies where drug and device can be optimized together. Based on ...

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respira...

Sperian Respiratory Protection USA, LLC

With nearly 6,000 employees worldwide, Sperian Protection (formerly Bacou-Dalloz) is the world's leading manufacturer of personal protective equipment. Sperian's expertise focuses on head, body and fa...

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory ...

More Information about "PARI Respiratory Equipment, Inc." on BioPortfolio

We have published hundreds of PARI Respiratory Equipment, Inc. news stories on BioPortfolio along with dozens of PARI Respiratory Equipment, Inc. Clinical Trials and PubMed Articles about PARI Respiratory Equipment, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PARI Respiratory Equipment, Inc. Companies in our database. You can also find out about relevant PARI Respiratory Equipment, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record